Harvard Gastrointestinal, Liver, and Pancreatic Pathology 2024

Overview

The Harvard Gastrointestinal, Liver, and Pancreatic Pathology 2024 course offers a comprehensive update on gastrointestinal, pancreatic, and hepatobiliary pathology. Delivered by faculty from Harvard Medical School and distinguished guest experts, this program integrates advances in morphology, staging criteria, novel immunohistochemistry markers, and molecular pathology. It is designed to support both academic and community pathologists in refining diagnostic strategies and maintaining current standards of practice.

On-demand gastroenterology pathology education — accessible anytime, anywhere.

Agenda

The 2024 agenda comprises detailed sessions covering benign and neoplastic disorders of the gastrointestinal tract, pancreas, and liver, featuring lectures, case seminars, and interactive Q&A segments structured across three days. All times are listed in Eastern Time.

• Introduction/Welcome — Jonathan N. Glickman, MD, PhD; Mark Redston, MD
• Barrett’s Esophagus and Associated Neoplasia — Mark Redston, MD
• Clinician’s Perspective- Upper GI Tract — Kunal Jajoo, MD
• Q&A — Mark Redston, MD; Kunal Jajoo, MD
• Gastric Polyps and Precursor Lesions — Stuti Shroff, MBBS, PhD
• Celiac Disease and its Differential Diagnosis — Jeffrey Goldsmith, MD
• Slide Seminar on Upper GI Tract — Miranda Machacek, MD, PhD
• Q&A — Jeffrey Goldsmith, MD; Miranda Machacek, MD, PhD; Stuti Shroff, MBBS, PhD
• Biopsy Diagnosis of Colitis — Mark Redston, MD
• IBD: Controversies and Challenges — Michael G. Drage, MD, PhD
• Colon Polyps and Polyposis — Jonathan N. Glickman, MD, PhD
• Q&A — Mark Redston, MD; Michael G. Drage, MD, PhD; Jonathan N. Glickman, MD, PhD
• Molecular Diagnostics in Colon Cancer and Screening for Lynch Syndrome — Jonathan Nowak, MD, PhD
• Challenges in Colon Cancer Staging — Mark Redston, MD
• Slide Seminar: Lower GI — Jonathan N. Glickman, MD, PhD
• Q&A — Jonathan Nowak, MD, PhD; Mark Redston, MD; Jonathan N. Glickman, MD, PhD
• GIST: From KIT to Succinate Dehydrogenase — Jason L. Hornick, MD, PhD
• Mesenchymal Tumors and Mesenchymal Polyps (other than GIST) — David Papke, MD, PhD
• Drug Induced Disorders of GI Tract — Mari Mino-Kenudson, MD
• Q&A — Mari Mino-Kenudson, MD; Jason L. Hornick, MD, PhD; David Papke, MD, PhD
• GI Lymphomas — Judith A. Ferry, MD
• Appendiceal Mucinous Neoplasms — Joseph Misdraji, MD
• Anal Pathology: Overview and Update — Jonathan N. Glickman, MD, PhD
• Q&A — Judith A. Ferry, MD; Joseph Misdraji, MD; Jonathan N. Glickman, MD, PhD
• Endocrine Tumors of the Tubal Gut — Raul S. Gonzalez, MD
• Cytology and Small Biopsy Diagnosis of Pancreaticobiliary Tumors — Lisa Zhang, MD
• Q&A — Raul S. Gonzalez, MD; Lisa Zhang, MD
• Surgical Pathology of Pancreatic Tumors — Mari Mino-Kenudson, MD
• Biliary Tract Neoplasia — Stuti Shroff, MBBS, PhD
• Slide Seminar: Instructive Cases in Pancreatic Pathology — Esther Baranov, MD
• Q&A — Mari Mino-Kenudson, MD; Stuti Shroff, MBBS, PhD; Esther Baranov, MD
• Medical Liver 1- Diagnostic Approach to Hepatitis — Angela Shih, MD
• Medical Liver 2- Fatty Liver — Lei Zhao, MD, PhD
• Clinician’s Perspective on Liver Biopsies — Daniel S. Pratt, MD
• Q&A — Angela Shih, MD; Lei Zhao, MD, PhD; Daniel S. Pratt, MD
• Liver Tumors — Rondell Graham, MBBS
• Medical Liver 3- Cholestatic Disorders — Angela Shih, MD
• Case Seminar: Challenging Liver Cases — Lei Zhao, MD, PhD
• Q&A — Lei Zhao, MD, PhD; Angela Shih, MD; Rondell Graham, MBBS
• Concluding Remarks — Jonathan N. Glickman, MD, PhD; Mark Redston, MD

Learning Objectives

• Describe the spectrum of benign and neoplastic gastrointestinal, pancreatic, and liver disorders using up-to-date nomenclature, diagnostic criteria, and reporting standards aligned with current practice.
• Evaluate gastrointestinal, pancreatic, and hepatobiliary cancers according to contemporary grading and staging guidelines.
• Assess challenging gastrointestinal lesions with an enhanced understanding of relevant histologic features and adjunctive diagnostic techniques.
• Interpret non-tumoral pathology of the GI tract and liver by integrating differential diagnoses with clinical information to support multidisciplinary care.

Speakers

This course features distinguished faculty from Harvard Medical School and guest experts recognized in gastrointestinal, pancreatic, and hepatobiliary pathology. The faculty represents a range of academic and clinical expertise to support interactive and current pathology practice.

• Jonathan N. Glickman, MD, PhD
• Mark Redston, MD
• Kunal Jajoo, MD
• Stuti Shroff, MBBS, PhD
• Jeffrey Goldsmith, MD
• Miranda Machacek, MD, PhD
• Michael G. Drage, MD, PhD
• Jonathan Nowak, MD, PhD
• Jason L. Hornick, MD, PhD
• David Papke, MD, PhD
• Mari Mino-Kenudson, MD
• Judith A. Ferry, MD
• Joseph Misdraji, MD
• Raul S. Gonzalez, MD
• Lisa Zhang, MD
• Esther Baranov, MD
• Angela Shih, MD
• Lei Zhao, MD, PhD
• Daniel S. Pratt, MD
• Rondell Graham, MBBS

Target Audience

This course is intended for specialty physicians and allied health professionals involved in the diagnosis and management of gastrointestinal, liver, and pancreatic disorders, including pathologists seeking updated expertise in morphology, staging, and molecular pathology relevant to clinical practice.

Why This Topic Matters

The Harvard Gastrointestinal, Liver, and Pancreatic Pathology 2024 course addresses critical advances in gastrointestinal pathology, emphasizing accurate diagnosis and reporting that inform patient care within gastroenterology and related specialties. It supports pathologists in maintaining current knowledge in a rapidly evolving field.

Hosted on MedHub Central, this program strengthens specialist expertise by integrating clinical relevance with cutting-edge morphological and molecular diagnostic approaches, enhancing confidence in pathology practice for improved professional performance.